Ligand Pharmaceuticals Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$59,666	$115,461	$47,627	$45,333
Gross Profit		90,641	44,720	40,484
EBITDA	56,780	149,232	20,898	-40,543
EBIT		141,137	12,376	-49,313
Net Income	44,784	117,273	4,847	-42,451
Net Change In Cash	59,666	115,461	47,627	45,333
Free Cash Flow	45,835	13,075	15,583	-25,730
Cash	733,521	139,376	67,669	47,989
Basic Shares	21,138	20,170	19,926	19,191

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$268,087	$167,133	$131,314	$196,245
Gross Profit		156,059	96,265	143,418
EBITDA	158,960	40,794	100,837	81,204
EBIT		5,555	64,316	37,810
Net Income	124,453	-4,032	52,154	-33,361
Net Change In Cash	268,087	167,133	131,314	196,245
Free Cash Flow	48,907	77,407	-4,272	119,927
Cash	733,521	72,307	22,954	45,006
Basic Shares	20,294	18,290	17,757	16,868